Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node

Surgery

Volumn 144, Issue 4, 2008, Pages 518-524

  Hulvat, Melissa ^a   Rajan, Prabha ^a   Rajan, Elizabeth ^a   Sarker, Sharfi ^a   Schermer, Carol ^a   Aranha, Gerard ^a   Yao, Katharine ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPH NODES; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 51449115296     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.06.006     Document Type: Article

References (36)

1. In: Greene F.L., Page D.L., and Fleming I.D. (Eds). AJCC Cancer Staging Manual. 6th edition (2002), Springer, New York
2. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione-Gertsch M., et al. Role of immunohistochemical detection of lymph node metastases in management of breast cancer. Lancet 354 (1999) 896-900
3. Querzoli P., Pedriali M., Rinaldi R., Lombardi A.R., Biganzoli E., Boracchi P., et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 12 (2006) 6696-6701
4. Cox C., Vrcel V., Riker A., White L., Allred N., Ramos D., et al. Significance of sentinel lymph node micrometastases on survival for patients with invasive breast cancer. Breast Cancer Res Treat 95 (2005) S12-S13
5. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
6. Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24 (2006) 3726-3734
7. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
8. Cochran A.J. In: Kirkham N., and Lemoine N.R. (Eds). Progress in Pathology Vol. 5 (2001), Greenwich Medical Media, London 45-56
9. Cserni G., Amendoeira I., Apostolikas N., Bellocq J., Bianchi S., Boecher W., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57 (2004) 695-701
10. Turner R.R., Weaver D.L., Cserni G., Lester S.C., Hirsch K., Elashoff D.A., et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 26 (2008) 258-263
11. Fitzgibbons P.L., Page D.L., Weaver D., Thor A.D., Allred C.D., Clark G.M., et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 966-978
12. Lyman G.H., Giuliano A.I., Sommerfield M.R., Benson A.B., Bodurka D.C., Burstein H.J., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
13. Cserni G., Bianchi S., Boecker W., Decker T., Lacerda M., Rank F., et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103 (2005) 358-367
14. Kuehn T., Bembenek A., Decker T., Munz D., Sautter-Bihl M., Untch M., et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 103 (2005) 451-461
15. Malbenco D.C., Dombi G.W., Kau T.Y., and Severson R.K. Significance of micrometastases on the survival of women with T1 breast cancer. Cancer 107 (2006) 1234-1239
16. Fisher E.R., Swamldoss S., Lee C.H., Rockette H., Redmond C., and Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42 (1978) 2025-2031
17. Huvos A.G., Hutter R.V., and Berg J.W. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173 (1971) 44-46
18. Hansen N., Grube B.J., Te W., Brennan M., Turner R.R., Guiliano A.E., et al. Clinical significance of axillary micrometastases in breast cancer: how small is too small?. Proc Am Soc Clin Oncol 20 (2001) A91
19. Chagpar A., Middleton L.P., Sahin A.A., Bernstam F.M., Kuerer H.M., Feig B.W., et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103 (2005) 1581-1586
20. Herbert G.S., Sohn V.Y., and Brown T.A. The impact of nodal isolated tumor cells on survival of breast cancer patients. Am J Surg 193 (2007) 571-574
21. Calhoun K.E., Hanse N.M., Turner R.R., and Giuliano A.E. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190 (2005) 588-591
22. Carter B.A., and Page D.L. Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact. J Clin Oncol 24 (2006) 1978-1979
23. Bleiweiss I., Nagi C., and Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24 (2006) 2013-2018
24. Carter B.A., Jensen R.A., Simpson J.F., et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113 (2000) 259-265
25. Viale G., Maiorano E., Pruneri G., Mastropasqua M.G., Valentini S., Galimberti V., et al. Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241 (2005) 319-325
26. Cserni G., Gregori D., Merletti F., Sapino A., Mano M.P., Ponti A., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Brit J Surg 91 (2004) 1245-1252
27. Bolster M.J., Peer P.G.M., Bult P., Thunnissen F., Schapers R., Meijer J.W., et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 14 (2006) 181-189
28. Van Rijk M.C., Peterse J.L., Nieweg O.E., Oldenburg H.S., Rutgers E.J., and Kroon B.B. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107 (2006) 467-471
29. Houvenaeghel G., Nos C., Mignotte H., et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24 (2006) 1814-1822
30. Pantel K., and Bradkenhoff R.H. Dissection the metastatic cascade. Nat Rev Cancer 4 (2004) 448-456
31. Mohammed R.A., Martin S.G., Gill M.S., Green A.R., Paish E.C., and Ellis I.O. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 31 (2007) 1825-1833
32. Gajdos C., Tartter P.I., and Bleiweiss I.J. Lymphatic invasion, tumor size and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 230 (1999) 692-696
33. Braun M., Flucke U., Debald M., Walgenbach-Bruenagel G., Walgenbach K., Holler T., et al. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat (2007) (Epub ahead of print)
34. Clahsen P.C., van de Velde C.J., Duval C., Pallud C., Mandard A.M., Delobelle-Deroide A., et al. The utility of mitotic index, oestrogen receptor and Ki67 measurement in the creation of novel prognostic indices for node-negative breast cancer. Eur J Surg Oncol 25 (1999) 356-363
35. Dowsett M., Smith I.E., Ebbs S.R., Dixon J.M., Skene A., A'hern R., et al. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst 99 (2007) 167-170
36. Baum M., Budzar A.U., Cuzick J., Forbes J., Houghton J.H., Klijn J.G., et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage cancer: first results of the ATAC randomized trial. Lancet 359 (2002) 2131-2139